Matches in Nanopublications for { ?s ?p "[PIK3CA and PTEN mutations are prevalent in colorectal cancer and potential markers of response to mitogen-activated protein/extracellular signal-regulated kinase inhibitors and anti-EGF receptor antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1073818.RAfRYiwt1pm6Kgp8Tz3cD5ihYrrAl1lzq4UJXKnWHre0I130_assertion description "[PIK3CA and PTEN mutations are prevalent in colorectal cancer and potential markers of response to mitogen-activated protein/extracellular signal-regulated kinase inhibitors and anti-EGF receptor antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073818.RAfRYiwt1pm6Kgp8Tz3cD5ihYrrAl1lzq4UJXKnWHre0I130_provenance.
- NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_assertion description "[PIK3CA and PTEN mutations are prevalent in colorectal cancer and potential markers of response to mitogen-activated protein/extracellular signal-regulated kinase inhibitors and anti-EGF receptor antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_provenance.